Increased shedding of soluble TNF-receptor 1 during hyperthermic TNF-α-based isolated limb perfusion

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Hyperthermia

• Publication date

  2011-01-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/02656736.2010.508067PMID 21073296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Imaging tumour physiology and vasculature to predict and assess response to heat

  2010cited by this paper
• Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue

  2010cited by this paper
• Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways.

  2009cited by this paper
• TNF‐mediated inflammatory disease

  2008cited by this paper
• Effectiveness of regional chemotherapy with TNF-α/Melphalan in advanced soft tissue sarcoma of the extremities

  2008cited by this paper
• Technology insight: Utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities.

  2006cited by this paper
• Extracellular TNFR1 Release Requires the Calcium-dependent Formation of a Nucleobindin 2-ARTS-1 Complex*

  2006cited by this paper
• Technology Insight: utility of TNF-α-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities

  2006cited by this paper
• Tumor Necrosis Factor-alpha Damages Tumor Blood Vessel Integrity by Targeting VE-Cadherin

  2006cited by this paper
• Efficiency of recombinant human TNF in human cancer therapy.

  2006influential reference
• Recombinant human tumor necrosis factor: an efficient agent for cancer treatment.

  2006cited by this paper
• The palliative value of tumor necrosis factor α‐based isolated limb perfusion in patients with metastatic sarcoma and melanoma

  2006cited by this paper
• TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility.

  2006cited by this paper
• Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.

  2006cited by this paper
• Changing the pathophysiology of solid tumours: The potential of TNF and other vasoactive agents

  2006cited by this paper
• Early destruction of tumor vasculature in tumor necrosis factor-&agr;-based isolated limb perfusion is responsible for tumor response

  2006cited by this paper
• Tissue physiology and the response to heat

  2006cited by this paper
• Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor‐α and melphalan for limb‐threatening soft tissue sarcoma

  2006cited by this paper
• Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?

  2005cited by this paper
• Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment

  2005cited by this paper
• Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-α be better?

  2005cited by this paper
• Alterations in tumor necrosis factor–induced endothelial cell procoagulant activity by hyperthermia

  2004cited by this paper
• Current uses of isolated limb perfusion in the clinic and a model system for new strategies.

  2003influential reference
• Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.

  2003cited by this paper
• Tumor necrosis factor signaling

  2003cited by this paper
• The TNFTNF Receptor System

  2002cited by this paper
• The TNF-TNF receptor system.

  2002cited by this paper
• Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability.

  2001cited by this paper
• Roles of tumor necrosis factor p55 and p75 receptors in TNF-α-induced vascular permeability

  2001cited by this paper
• Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment.

  2000cited by this paper
• Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

  2000cited by this paper
• Humoral Immune Response During Coronary Artery Bypass Grafting: A Comparison of Limited Approach, “Off-Pump” Technique, and Conventional Cardiopulmonary Bypass

  2000cited by this paper
• Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion and procoagulant activity in endothelial cells.

  2000cited by this paper
• Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats

  1999influential reference
• Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.

  1998cited by this paper
• Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion.

  1997cited by this paper
• The potential biological and clinical significance of the soluble tumor necrosis factor receptors.

  1996cited by this paper
• Tumor necrosis factor: function, release and clearance.

  1996cited by this paper
• Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.

  1995cited by this paper
• Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs.

  1995cited by this paper
• Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection.

  1994cited by this paper
• Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils.

  1994cited by this paper
• Tissue distribution and clearance of soluble murine TNF receptors in mice.

  1994cited by this paper
• Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis

  1993cited by this paper
• Variation in serum levels of the soluble TNF receptors among healthy individuals.

  1992cited by this paper
• Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.

  1992cited by this paper
• The changing role of amputation for soft tissue sarcoma of the extremity in adults.

  1992cited by this paper
• Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.

  1991cited by this paper
• Shedding of tumor necrosis factor receptors by activated human neutrophils

  1990cited by this paper
• Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

  1968cited by this paper

• Weak association of a TNFRSF1A polymorphism with Behcet's disease in Chinese Han.

  2020cites this paper
• CD30‐positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: A report of two cases and analysis of CD30 expression

  2014cites this paper
• Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma

  2012cites this paper